These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35617800)
41. [Oxidative stress and calcium/calmodulin-dependent protein kinase II contribute to the development of sustained β adrenergic receptor-stimulated cardiac hypertrophy in rats]. Liu YL; Liu B; Qu YY; Chai HJ; Li R; Zhang L Sheng Li Xue Bao; 2013 Feb; 65(1):1-7. PubMed ID: 23426507 [TBL] [Abstract][Full Text] [Related]
42. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476 [TBL] [Abstract][Full Text] [Related]
43. Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure. Wang Y; Tandan S; Cheng J; Yang C; Nguyen L; Sugianto J; Johnstone JL; Sun Y; Hill JA J Biol Chem; 2008 Sep; 283(37):25524-25532. PubMed ID: 18622016 [TBL] [Abstract][Full Text] [Related]
44. Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Mesubi OO; Anderson ME Cardiovasc Res; 2016 Apr; 109(4):542-57. PubMed ID: 26762270 [TBL] [Abstract][Full Text] [Related]
45. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. Singh MV; Swaminathan PD; Luczak ED; Kutschke W; Weiss RM; Anderson ME J Mol Cell Cardiol; 2012 May; 52(5):1135-44. PubMed ID: 22326848 [TBL] [Abstract][Full Text] [Related]
46. Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca Bezzerides VJ; Caballero A; Wang S; Ai Y; Hylind RJ; Lu F; Heims-Waldron DA; Chambers KD; Zhang D; Abrams DJ; Pu WT Circulation; 2019 Jul; 140(5):405-419. PubMed ID: 31155924 [TBL] [Abstract][Full Text] [Related]
47. Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation. Yao Y; Li F; Zhang M; Jin L; Xie P; Liu D; Zhang J; Hu X; Lv F; Shang H; Zheng W; Sun X; Duanmu J; Wu F; Lan F; Xiao RP; Zhang Y Circ Res; 2022 Mar; 130(6):887-903. PubMed ID: 35152717 [TBL] [Abstract][Full Text] [Related]
48. Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use? Grandi E; Dobrev D J Mol Cell Cardiol; 2018 Aug; 121():300-303. PubMed ID: 29079077 [TBL] [Abstract][Full Text] [Related]
49. Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia. Greer-Short A; Musa H; Alsina KM; Ni L; Word TA; Reynolds JO; Gratz D; Lane C; El-Refaey M; Unudurthi S; Skaf M; Li N; Fedorov VV; Wehrens XHT; Mohler PJ; Hund TJ Heart Rhythm; 2020 Mar; 17(3):503-511. PubMed ID: 31622781 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Li N; Wang T; Wang W; Cutler MJ; Wang Q; Voigt N; Rosenbaum DS; Dobrev D; Wehrens XH Circ Res; 2012 Feb; 110(3):465-70. PubMed ID: 22158709 [TBL] [Abstract][Full Text] [Related]
51. Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation. Purohit A; Rokita AG; Guan X; Chen B; Koval OM; Voigt N; Neef S; Sowa T; Gao Z; Luczak ED; Stefansdottir H; Behunin AC; Li N; El-Accaoui RN; Yang B; Swaminathan PD; Weiss RM; Wehrens XH; Song LS; Dobrev D; Maier LS; Anderson ME Circulation; 2013 Oct; 128(16):1748-57. PubMed ID: 24030498 [TBL] [Abstract][Full Text] [Related]
52. The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias. Westenbrink BD; Edwards AG; McCulloch AD; Brown JH Expert Opin Ther Targets; 2013 Aug; 17(8):889-903. PubMed ID: 23789646 [TBL] [Abstract][Full Text] [Related]
53. Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart. Warren M; Sciuto KJ; Taylor TG; Garg V; Torres NS; Shibayama J; Spitzer KW; Zaitsev AV Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H752-H767. PubMed ID: 28130334 [TBL] [Abstract][Full Text] [Related]
54. The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1. Sadredini M; Manotheepan R; Lehnart SE; Anderson ME; Sjaastad I; Stokke MK Physiol Rep; 2021 Sep; 9(18):e15030. PubMed ID: 34558218 [TBL] [Abstract][Full Text] [Related]
55. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Curran J; Hinton MJ; Ríos E; Bers DM; Shannon TR Circ Res; 2007 Feb; 100(3):391-8. PubMed ID: 17234966 [TBL] [Abstract][Full Text] [Related]
60. A role for calcium/calmodulin-dependent protein kinase II in cardiac disease and arrhythmia. Hund TJ; Rudy Y Handb Exp Pharmacol; 2006; (171):201-20. PubMed ID: 16610345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]